相关实验视频
Updated: Jan 14, 2026

12:08
Improving IV Insulin Administration in a Community Hospital
Published on: June 11, 2012
19.3K
探索气候意识的药房:对社区药剂师的考虑
Jamie Y Park1, Sarah Semchism2, Claire V Moyana2
1Institute of Health Policy, Management and Evaluation, University of Toronto, Toronto, ON M5T 3M6, Canada.
The International journal of pharmacy practice
|October 24, 2025
概括
社区药房可以通过利用已识别的减缓和适应资源,采取气候意识的做法. 药剂师在地球健康方面发挥着关键作用,以患者为中心的方法提高了实施.
科学领域:
- 环境健康 环境健康
- 制药科学 制药科学
- 公共卫生 公共卫生
背景情况:
- 气候变化对医疗保健系统和患者护理构成重大风险.
- 社区药房对于可访问的医疗保健至关重要,必须应对与气候有关的挑战.
- 调查社区药房在气候行动中的作用至关重要.
研究的目的:
- 确定支持气候意识药房实践的资源.
- 探索将气候考虑纳入社区药房运营的机会.
主要方法:
- 跨越国际司法管辖区对资源的环境扫描.
- 与加拿大,英国,爱尔兰和挪威的关键信息人进行了定性采访.
- 资源的分类和对实施战略的反.
主要成果:
- 115个来源和12个关键信息提供者为这项研究做出了贡献.
- 资源被分为临床和运营方面的考虑,包括缓解和适应.
- 关键信息人员证实了资源效用,并强调了以患者为中心的实施,尽管存在限制.
结论:
- 在全球范围内已经确定了气候意识社区药房实践的可行的策略.
- 药剂师已经通过现有实践为地球健康做出了贡献.
- 提高对副效益的认识可以赋予药剂师采取气候意识的方法的权力.
相关概念视频
Drug Dosing: Geriatric Patients
222
Elderly individuals encompass a diverse population with varying degrees of age-related physiological changes. Defining the elderly presents challenges, as the geriatric population is often arbitrarily categorized as individuals older than 65. However, many individuals in this group lead active and healthy lives, with an increasing number surpassing 85 years and falling into the older elderly category. Physiological changes associated with aging impact performance capacity and homeostatic...
222
Chronopharmacokinetics: Circadian Rhythms and Influence on Drug Response
350
Circadian rhythms are cyclic changes that are crucial in plasma drug concentrations. Various standard circadian parameters, including core body temperature, heart rate, and other cardiovascular factors, directly impact disease states and the therapeutic response to drug therapy.
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
The time of drug administration is an important factor to consider, as it can influence the toxic dose of a drug. For example, a study conducted by Prins et al. in 1997 examined the effects of the timing of...
350
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Distribution
228
Drug distribution in the human body is influenced by several factors, including plasma protein concentration, body composition, blood flow, tissue-protein concentration, and tissue fluid pH. Among these, changes in plasma protein concentration and body composition due to aging significantly affect how drugs are distributed within the body. Specifically, aging is associated with a decrease in albumin levels by about 10% and an increase in α1-acid glycoprotein levels. These alterations are...
228
Drug Dosing: Obese Patients
218
In the United States, obesity is a prominent concern. It is linked to heightened mortality rates due to increased occurrences of conditions such as hypertension, atherosclerosis, coronary artery disease, and diabetes compared to nonobese individuals. A patient is classified as obese if their actual body weight surpasses the ideal or desirable body weight by 20%, based on Metropolitan Life Insurance Company data. Ideal body weights consider average weights and heights for males and females...
218
Pharmacokinetics in Geriatric Patients: Effect of Age on Drug Absorption
224
As individuals age, their body's physiology evolves, affecting drug pharmacokinetics. The most apparent changes occur in the gastrointestinal tract, where an increase in gastric pH, a delay in gastric emptying, and a reduction in gastrointestinal motility are observed. Remarkably, these changes do not substantially modify the absorption of orally administered drugs, particularly those absorbed via passive diffusion.Transdermal drug delivery emerges as a highly viable method for older adults due...
224
Pharmaceutical Alternatives: Polymorphic Form-Related and Particle Size-Related Therapeutic Nonequivalence
148
Changes in polymorphic forms can significantly influence the bioavailability of poorly soluble drugs. Although the FDA defines pharmaceutical equivalence based on having the same active ingredient, dosage form, and route of administration, it does not automatically disqualify products with different polymorphic forms. This means two products with different polymorphs can still be deemed pharmaceutically equivalent. However, polymorphic differences can affect properties like wettability,...
148

